BlackRock, Inc. 13D and 13G filings for AngioDynamics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | AngioDynamics, Inc. ANGO | BlackRock Inc. BLK | 2,918,422 7.200% | -1,023,208 (-25.96%) | Filing |
| 2025-02-05 5:28 pm Sale | 2024-12-31 | 13G | AngioDynamics, Inc. ANGO | BlackRock Inc. BLK | 3,941,630 9.700% | -718,789 (-15.42%) | Filing |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | AngioDynamics, Inc. ANGO | BlackRock Inc. BLK | 4,660,419 11.500% | 0 (Unchanged) | Filing |
| 2024-10-23 5:04 pm Sale | 2024-09-30 | 13G | AngioDynamics, Inc. ANGO | BlackRock Inc. BLK | 4,660,419 11.500% | -383,679 (-7.61%) | Filing |
| 2024-01-23 4:14 pm Purchase | 2023-12-31 | 13G | AngioDynamics, Inc. ANGO | BlackRock Inc. BLK | 5,044,098 12.700% | 882,214 (+21.20%) | Filing |
| 2023-10-06 2:34 pm Sale | 2023-09-30 | 13G | AngioDynamics, Inc. ANGO | BlackRock Inc. BLK | 4,161,884 10.500% | -2,552,013 (-38.01%) | Filing |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | AngioDynamics, Inc. ANGO | BlackRock Inc. BLK | 6,713,897 17.200% | 0 (Unchanged) | Filing |
| 2023-01-20 09:43 am Purchase | 2022-12-31 | 13G | AngioDynamics, Inc. ANGO | BlackRock Inc. BLK | 6,713,897 17.200% | 434,062 (+6.91%) | Filing |
| 2022-01-28 1:54 pm Purchase | 2021-12-31 | 13G | AngioDynamics, Inc. ANGO | BlackRock Inc. BLK | 6,279,835 16.200% | 7,002 (+0.11%) | Filing |